XML 32 R15.htm IDEA: XBRL DOCUMENT v3.25.0.1
GOODWILL AND OTHER INTANGIBLE ASSETS
12 Months Ended
Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND OTHER INTANGIBLE ASSETS

NOTE 6. GOODWILL AND OTHER INTANGIBLE ASSETS

 

In accordance with ASC 350-20-35-45, all the Company’s goodwill is assigned to a single operating and reporting unit. All acquisitions made by the Company are in one general insurance agency industry and operate in a very similar economic and regulatory environment. The Company’s operations team leadership reports directly to the Chief Executive Officer (“CEO”) on a quarterly basis. Additionally, the CEO who is responsible for the strategic direction of the Company reviews the operations of the insurance agency business collectively, as one segment.

 

For the year ended December 31, 2023, due to a declining market capitalization, the Company performed a quantitative goodwill impairment test utilizing the discounted cash flow method of the income approach with market participant control adjustments in consideration of market capitalization, and concluded that the Company’s carrying value of equity exceeded its fair value of equity in the approximate amount of $7,594,000 which the Company recognized as a goodwill impairment charge, presented in the goodwill impairment account on the consolidated statements of operations for the year ended December 31, 2023. The Company also recognized an additional goodwill impairment of $4,825,634 upon the abandonment of Medigap, presented in the loss from discontinued operations before tax account in the consolidated statements of operations for the year ended December 31, 2023.

 

The following table rolls forward the Company’s goodwill balance for the periods ended December 31, 2024 and 2023 exclusive of discontinued operations. 

 

    Goodwill  
December 31, 2022   $ 14,287,099  
Goodwill impairment     (7,594,000
December 31, 2023, and December 31, 2024     6,693,099  

 

 

The following table rolls forward the Company’s goodwill balance for the periods ended December 31, 2024, and December 31, 2023 inclusive of discontinued operations.

 

    Goodwill  
December 31, 2022   $ 19,112,733  
Goodwill impairment (Medigap-discontinued operations)     (4,825,634
Goodwill impairment     (7,594,000
December 31, 2024     6,693,099  

 

Intangible Asset Impairments: During the year ended December 31, 2024, certain intangible assets stemming from discontinued operations which were originally transferred to the Company’s operating entity, were determined to have carrying values exceeding fair value, and thus were considered impaired. These intangible assets consisted of customer relationships, and internally developed and purchased software, with respective net of accumulated amortization asset values of $3,802,438, $65,411, and $54,261. The write-offs resulted in a total asset impairment charge of $3,922,110, recorded in the asset impairment account on the consolidated statements of operations for the year ended December 31, 2024.

 

The following table sets forth the major categories of the Company’s intangible assets and the weighted-average remaining amortization period as of December 31, 2024:

 

    Weighted
Average
Remaining
Amortization
period (Years)
    Gross
Carrying
Amount
    Accumulated
Amortization
   

Net 

Carrying
Amount
 

 
Trade name and trademarks     1.8     $ 1,808,087     $ (1,586,651 )   $ 221,436  
Internally developed software     2.3       1,733,817       (948,706 )     785,111  
Customer relationships     5.8       7,372,290       (3,180,376 )     4,191,914  
Purchased software     2.0       565,704       (563,470 )     2,234  
Non-competition agreements     1.3       3,504,810       (3,281,608 )     223,202  
Total           $ 14,984,708     $ (9,560,811 )   $ 5,423,897  

 

The following table sets forth the major categories of the Company’s intangible assets and the weighted-average remaining amortization period as of December 31, 2023:

  

    Weighted
Average
Remaining
Amortization
period (Years)
    Gross
Carrying
Amount
    Accumulated
Amortization
   

Net

Carrying
Amount

 
Trade name and trademarks     1.5     $ 1,807,189     $ (1,320,939 )   $ 486,250  
Internally developed software     3.2       1,798,922       (650,029 )     1,148,893  
Customer relationships     8.0       11,922,290       (3,193,629 )     8,728,661  
Purchased software     0.3       667,206       (618,418 )     48,788  
Video Production Assets     -       50,000       (50,000 )     -  
Non-competition agreements     0.9       3,504,810       (2,874,645 )     630,165  
Total           $ 19,750,417     $ (8,707,660 )   $ 11,042,757  

 

Amortization expense is $1,755,721 and $2,563,559 for the years ended December 31, 2024, and 2023, respectively.

 

 

The following table reflects expected amortization expense as of December 31, 2024, for each of the following five years and thereafter:

 

Years ending December 31,   Amortization Expense  
2025   $ 1,404,828  
2026     1,156,003  
2027     815,374  
2028     724,553  
2029     523,619  
Thereafter     799,520  
Total   $ 5,423,897